Life Sciences Ontario
Life Sciences Ontario (LSO) strives to be the unified Voice of Life Sciences in Ontario by representing the interests of the diverse life sciences community in the province through advocacy, education, facilitation of economic development and promotion of the industry locally, nationally and internationally. Together we are a strong, innovative sector with significant socioeconomic contributions to the province of Ontario. We hope you will consider joining LSO and help us to achieve our vision for Ontario's life sciences sector - "Diversity of Members, Unity of Voice".
Life Sciences Ontario strengthens its leadership with New Chair, Board Members
Thursday, March 23, 2017
Life Sciences Ontario (LSO) today announced a new Chair of its Board of Directors, along with two new Board members, strengthening its capacity to foster growth and commercialization in Ontarios life sciences sector.
Canadian collaboration to accelerate development of cancer treatments
Thursday, March 23, 2017
An innovative collaboration between government, industry, and academia aims to accelerate the development of cancer treatments in Canada. The National Research Council of Canada (NRC) and the Toronto-based Centre for the Commercialization of Antibodies and Biologics (CCAB) have put in place over $1M in collaborative agreements over the past year to produce and test therapeutic antibodies discovered at the University of Toronto (U of T).
Will there be innovation in the Innovation Budget?
Tuesday, March 21, 2017
The Trudeau government, Toronto Star columnist Paul Wells noted, came out of the gate hell-bent on consulting us.
And consult us they did. The Liberals election in October 2015 created renewed optimism for science and knowledge-based industries. They appointed a Minister of Science and shunted science into Industry Canadas nomenclature. Minister Navdeep Bains launched a broad consultation to develop an Innovation Agenda for Canada.
Algae Dynamics Corp Announces Research Agreement With University Of Waterloo To Investigate Use Of Cannabis Oil In The Context Of Cancer
Friday, February 24, 2017
ALGAE DYNAMICS CORP (OTCQB:ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo(R) cultivation and extraction system for the growth of algae strains for use in the food and health supplement industry, today announced a research agreement with the University of Waterloo to perform fundamental research on cannabis oil and its constituents in the context of the development and treatment of cancers of the colorectum, pancreas, breast and prostate. The Sponsored Research Agreement is entitled Studies on botanical oils from Algae Dynamics.
Big Pharma: Getting away with murder, or saving lives?
Friday, February 3, 2017
Jason Field, Life Sciences Ontario President & CEO, on the dangerous myths putting Canadas pharmaceutical industry at risk
US President Donald Trump recently sent biotech stocks tumbling with his claim that the pharmaceutical industry is getting away with murder. In a meeting with major US pharma companies this week, he again slammed pricing, and said he wants to see more drug manufacturing return to the US.